Irish HSE rejects MS drug Fampridine again

Dalfampridine, or Ampyra, is a potassium channel blocker that is shown to improve visual function, motor skills and relieve fatigue in MS patients.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Irish HSE rejects MS drug Fampridine again

Post by MSUK » Thu Oct 30, 2014 12:56 am

Irish health service executive rejects MS drug Fampridine again

Decision comes as a blow to patients who are paying up to €500 a month for Fampridine.

The Health Service Executive has rejected a second application from the makers of a drug that helps people with multiple sclerosis to walk to have it covered by State-funded drug schemes...... Read More - http://www.ms-uk.org/ampyra
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post